Cancer Research 2010 AACR Elections  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Decaussin, G.
Right arrow Articles by Ooka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Decaussin, G.
Right arrow Articles by Ooka, T.
[Cancer Research 60, 5584-5588, October 1, 2000]
© 2000 American Association for Cancer Research


Virology

Expression of BARF1 Gene Encoded by Epstein-Barr Virus in Nasopharyngeal Carcinoma Biopsies1

Gisèle Decaussin, Fatima Sbih-Lammali, Mireille de Turenne-Tessier, Abdelmadjide Bouguermouh and Tadamasa Ooka2

Laboratoire de Virologie Moléculaire, UMR5537, Centre National de la Recherche Scientifique, Faculté de Médecine R.T.H. Laënnec, Université Claude Bernard Lyon-1, 69372 Lyon Cedex 08, France [G. D., F. S-L., M. D. T-T., T. O.], and Département de Virologie Humaine, Institut Pasteur d’Alger, Sidi-Frejd, Tipaza, Algeria [A. B.]

We reported previously that the EBV BARF1 open reading frame encodes a Mr 31,000–33,000 protein (p31) with potential transforming and oncogenic properties. This gene was found capable of transforming both: (a) the rodent fibroblast lines Balbc/3T3 and NIH3T3 into cells producing aggressive tumors in newborn rats; and (b) the human EBV-negative B-cell line Louckes into cells leading to small tumors, which disappeared 3 weeks after injection. Our recent study showed that BARF1 ORF expression may confer the property of immortalization to primary kidney epithelial cells (M. X. Wei et al., Oncogene, 14: 3073–3081, 1997). Because this suggested that BARF1 could be involved in epithelial malignancy, we investigated its transcriptional and translational expressions in Algerian nasopharyngeal carcinoma (NPC) biopsies by reverse transcription-PCR and immunoblotting using rabbit polyclonal antisera prepared against two synthetic peptides corresponding to distinct, predicted epitopes of the BARF1 protein (NGGVMKEKD, amino acids 172–180, and GKNDKEE, amino acids 203–209). The BARF1 ORF was found to be transcribed and translated in >85% of our NPC biopsies, with high p31 protein level detected in several NPC patient biopsies as well as in NPC-derived xenografts. Our observation of BARF1 expression in a large proportion of NPC epithelial cells suggests that this EBV gene might play an important role in the malignant transformation of human epithelial cells in vivo.




This article has been cited by other articles:


Home page
Cancer Res.Home page
E. Seto, T. Ooka, J. Middeldorp, and K. Takada
Reconstitution of Nasopharyngeal Carcinoma-Type EBV Infection Induces Tumorigenicity
Cancer Res., February 15, 2008; 68(4): 1030 - 1036.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. de Turenne-Tessier and T. Ooka
Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide
J. Gen. Virol., October 1, 2007; 88(10): 2656 - 2661.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Houali, X. Wang, Y. Shimizu, D. Djennaoui, J. Nicholls, S. Fiorini, A. Bouguermouh, and T. Ooka
A New Diagnostic Marker for Secreted Epstein-Barr Virus Encoded LMP1 and BARF1 Oncoproteins in the Serum and Saliva of Patients with Nasopharyngeal Carcinoma
Clin. Cancer Res., September 1, 2007; 13(17): 4993 - 5000.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-H. Ho, C.-F. Hsu, P.-F. Fong, S.-K. Tai, S.-L. Hsieh, and C.-J. Chen
Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter
J. Virol., May 1, 2007; 81(9): 4837 - 4847.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. J. C. Stevens, S. A. W. M. Verkuijlen, B. Hariwiyanto, Harijadi, J. Fachiroh, D. K. Paramita, I. B. Tan, S. M. Haryana, and J. M. Middeldorp
Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from Indonesia
J. Clin. Microbiol., July 1, 2005; 43(7): 3066 - 3073.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Sheng, G. Decaussin, A. Ligout, K. Takada, and T. Ooka
Malignant Transformation of Epstein-Barr Virus-Negative Akata Cells by Introduction of the BARF1 Gene Carried by Epstein-Barr Virus
J. Virol., March 15, 2003; 77(6): 3859 - 3865.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.